- ML-guided antibody design with wet lab iteration
- Focuses on antibody discovery depth over broad coverage
- Supports organization-wide antibody discovery programs
- Provides rapid design-to-data cycles
- Demonstrated pharmaceutical partnerships
Best for
Antibody engineering and biotech teams
Pricing
Custom
Free plan
Check vendor
SoftFinders Score
7.11 / 10
Overview
What is BigHat Biosciences?
BigHat Biosciences is an AI antibody design company for biotech teams, pairing machine learning with a synthesis-and-test lab to support antibody engineering.
- Research focus: It supports R&D acceleration and computational biology rather than guaranteed clinical outcomes, with downstream validation still required for candidates.
- Best-fit environment: Antibody engineering and biotech teams may benefit most when ML-guided design and wet-lab iteration align with established discovery workflows.
- Engagement model: Work typically runs through pharma partnerships rather than self-service subscriptions, making data access, validation timelines, and collaboration structure important considerations.
- Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, while engagement remains partnership and pipeline-led.
BigHat Biosciences is best assessed through a pilot that tests workflow fit, data requirements, and collaboration needs before wider commitment.
KEY FEATURES
What you get out of the box
Multi Omics
Integrates genomic and other omics data sources
Lab Integration
Connects discovery insights with wet-lab workflows
Partner Workflows
Workflows for pharma partner collaborations
Target Discovery
Identifies potential drug targets from biological data
Molecule Design
Generates and ranks small molecule candidates
Protein Modeling
Predicts and designs protein structures
High-Throughput Characterization
Runs 20+ assays across antibody properties.
USE CASES
Where teams put it to work
Editorial Take
What we like, and what to verify
- Engagement remains partnership and pipeline-led
- Drug success still depends on downstream trials
- Pricing is sales-led and needs scoping upfront
- Primarily focused on protein therapeutics
- Partnership engagement is required for access
- Public pricing is not available
Screenshots
A look inside

Alternatives
Tools to consider next
Why consider it
Generative chemistry and synthesis planning AI
Why consider it
AI protein design for wet labs
Why consider it
Molecular structure prediction for discovery research
Why consider it
Spatial biology models for cancer targets
Why consider it
Generative protein design across modalities
Why consider it
Biomedical evidence and reasoning for R&D
USER REVIEWS
BigHat Biosciences Reviews
Published user reviews are moderated and kept separate from the SoftFinders Score.
No published reviews yet.
Reviews from real users will appear here once published.
Used BigHat Biosciences?
Share your experience with other buyers.
FAQ
